+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Extracorporeal Membrane Oxygenation Machine Market (2023-2028) by Components, Modality, Patient Type, Applications, End-Users, and Geography, Competitive Analysis, Impact of Covid-19, Impact of Economic Slowdown & Impending Recession with Ansoff Analysis

  • PDF Icon


  • 170 Pages
  • January 2023
  • Region: Global
  • Infogence Global Research
  • ID: 5515487

The extracorporeal membrane oxygenation (ECMO) market has seen high demand for new technologies, products and service offerings

The Global Extracorporeal Membrane Oxygenation Machine Market is estimated to be USD 379.53 Mn in 2023 and is expected to reach USD 574.4 Mn by 2028, growing at a CAGR of 8.64%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

The Global Extracorporeal Membrane Oxygenation Machine Market is segmented based on Components, Modality, Patient Type, Applications, End-Users, and Geography.
  • By Components, the market is classified into Pumps, Oxygenator, Controllers, Cannulas, and Accessories.
  • By Modality, the market is classified into Veno-Venous ECMO, Veno-Arterial ECMO, and Arterio-Venous ECMO.
  • By Patient Type, the market is classified into Neonates and Adults.
  • By Applications, the market is classified into Respiratory, Cardiac, and Extracorporeal Cardiopulmonary Resuscitation.
  • By End-Users, the market is classified into Hospitals, Home Care Settings, and Ambulatory Centers.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are LivaNova PLC, Medtronic PLC, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Extracorporeal Membrane Oxygenation Machine Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Extracorporeal Membrane Oxygenation Machine Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Extracorporeal Membrane Oxygenation Machine Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the Impact of Economic Slowdown & Impending Recession on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders

2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study

3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations and Outlook

4 Market Dynamics
4.1 Drivers
4.1.1 Rising Number of Acute Respiratory and Cardiac Failure
4.1.2 Higher Need for a Life Support Machine Due to the Poor Functioning of Body Organs
4.1.3 Growing Requirement During Critical Pre and Post-Surgeries in Hospitals
4.2 Restraints
4.2.1 High Cost of Machines
4.3 Opportunities
4.3.1 Technological Advancement in ECMO Machines
4.4 Challenges
4.4.1 Complex and High-Risk Therapy
4.4.2 Lack Skilled Professionals

5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 Impact of Economic Slowdown & Impending Recession
5.5 Ansoff Matrix Analysis

6 Global Extracorporeal Membrane Oxygenation Machine Market, By Components
6.1 Introduction
6.2 Pumps
6.2.1 Roller Pumps
6.2.2 Centrifugal Pumps
6.3 Oxygenator
6.4 Controllers
6.5 Cannulas
6.6 Accessories

7 Global Extracorporeal Membrane Oxygenation Machine Market, By Modality
7.1 Introduction
7.2 Veno-Venous ECMO
7.3 Veno-Arterial ECMO

8 Arterio-Venous ECMOGlobal Extracorporeal Membrane Oxygenation Machine Market, By Patient Type
8.1 Introduction
8.2 Neonates
8.3 Pediatric
8.4 Adult

9 Global Extracorporeal Membrane Oxygenation Machine Market, By Applications
9.1 Introduction
9.2 Respiratory
9.3 Cardiac
9.4 Extracorporeal Cardiopulmonary Resuscitation

10 Global Extracorporeal Membrane Oxygenation Machine Market, By End-User
10.1 Introduction
10.2 Hospitals
10.3 Home Care Settings
10.4 Ambulatory Centers

11 Americas' Extracorporeal Membrane Oxygenation Machine Market
11.1 Introduction
11.2 Argentina
11.3 Brazil
11.4 Canada
11.5 Chile
11.6 Colombia
11.7 Mexico
11.8 Peru
11.9 United States
11.10 Rest of Americas

12 Europe's Extracorporeal Membrane Oxygenation Machine Market
12.1 Introduction
12.2 Austria
12.3 Belgium
12.4 Denmark
12.5 Finland
12.6 France
12.7 Germany
12.8 Italy
12.9 Netherlands
12.10 Norway
12.11 Poland
12.12 Russia
12.13 Spain
12.14 Sweden
12.15 Switzerland
12.16 United Kingdom
12.17 Rest of Europe

13 Middle East and Africa's Extracorporeal Membrane Oxygenation Machine Market
13.1 Introduction
13.2 Egypt
13.3 Israel
13.4 Qatar
13.5 Saudi Arabia
13.6 South Africa
13.7 United Arab Emirates
13.8 Rest of MEA

14 APAC's Extracorporeal Membrane Oxygenation Machine Market
14.1 Introduction
14.2 Australia
14.3 Bangladesh
14.4 China
14.5 India
14.6 Indonesia
14.7 Japan
14.8 Malaysia
14.9 Philippines
14.10 Singapore
14.11 South Korea
14.12 Sri Lanka
14.13 Thailand
14.14 Taiwan
14.15 Rest of Asia-Pacific

15 Competitive Landscape
15.1 Competitive Quadrant
15.2 Market Share Analysis
15.3 Strategic Initiatives
15.3.1 M&A and Investments
15.3.2 Partnerships and Collaborations
15.3.3 Product Developments and Improvements

16 Company Profiles
16.1 Abiomed, Inc.
16.2 Braille Biomedical
16.3 Chalice Medical Ltd.
16.4 CytoSorbents Corp.
16.5 Edwards Lifesciences Corp.
16.6 Eurosets Srl
16.7 Fresenius Medical care Ag & Co. KGaA
16.8 Getinge Group
16.9 Hemovent GmbH
16.10 LivaNova PLC
16.11 MC3, Inc
16.12 Medtronic PLC
16.13 MicroPort Scientific Corp.
16.14 Nipro Corp.
16.15 OriGen Biomedical
16.16 Spectrum Medical
16.17 Terumo Corp.
16.18 Xenios Ag

17 Appendix
17.1 Questionnaire

Companies Mentioned

  • Abiomed, Inc.
  • Braille Biomedical
  • Chalice Medical Ltd.
  • CytoSorbents Corp.
  • Edwards Lifesciences Corp.
  • Eurosets Srl
  • Fresenius Medical care Ag & Co. KGaA
  • Getinge Group
  • Hemovent GmbH
  • LivaNova PLC
  • MC3, Inc
  • Medtronic PLC
  • MicroPort Scientific Corp.
  • Nipro Corp.
  • OriGen Biomedical
  • Spectrum Medical
  • Terumo Corp.
  • Xenios Ag